Landscapes / Companies
RECORDATI GROUP not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
Drugs
2
in active trials · 10 in all
Trials
3 active
13 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Cortisol synthesis inhibitor |
Recordati · Novartis |
Approved | 21 Jul 2027Phase 2 trial completes | ||
| Next date | 21 Jul 2027 · Phase 2 trial completes | ||||
| Also tested for | Cushing Syndrome, Hypertension and 1 more | ||||
| Open drug page | |||||
Somatostatin analog |
Approved | — | |||
| Also tested for | Post-Bariatric Hypoglycemia | ||||
| Open drug page | |||||
About
- No active trial
- 8 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021